COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020

Nwosu, Benjamin Udoka; Al-Halbouni, Layana; Parajuli, Sadichchha; Jasmin, Gabrielle; Zitek-Morrison, Emily; Barton, Bruce

doi:10.3389/fendo.2021.703905

Cited by 17 publications

(17 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These perceived improvements in glycemic control are consistent with findings of recent studies conducted among children and adults with T1DM during the COVID-19 pandemic in other countries, 19 such as Italy, 8 - 10 , 19 , 20 , Spain, 19 the United Kingdom, 19 and Malaysia. 11 However, literature remains mixed 19 because several other studies, including those conducted in the United States, 6 , 21 Saudi Arabia, 22 Japan, 23 India, 24 and Italy, 25 reported either poorer glycemic control or no significant change during the pandemic.…”

Section: Discussionmentioning

confidence: 99%

Impacts of the COVID-19 Pandemic on Pediatric Type 1 Diabetes Management: A Qualitative Study

Ferguson

Moore

Kaidbey

et al. 2022

The Science of Diabetes Self-Management and Care

View full text Add to dashboard Cite

Purpose: The purpose of this study was to understand impacts of the coronavirus (COVID-19) pandemic on pediatric type 1 diabetes management. Methods: In-depth qualitative interviews were conducted with 15 parents of children (age 6-12 years) with type 1 diabetes. Parents responded to 8 open-ended questions about their experiences managing their children’s type 1 diabetes during the COVID-19 pandemic. All interviews were transcribed, coded, and analyzed using qualitative thematic methods. Results: Parents reported both positive and negative aspects of managing their children’s type 1 diabetes during the COVID-19 pandemic. Facilitators of diabetes management included spending more time together at home and enhanced convenience of telehealth appointments and online supply ordering. Parents also described difficulties managing their children’s type 1 diabetes during the COVID-19 pandemic, including a lack of structure in their child’s daily routine, which led to increases in sedentary behavior. Furthermore, they reported psychosocial challenges of type 1 diabetes management, which were exacerbated by the pandemic. Conclusion: While the COVID-19 pandemic was described as having overall positive impacts on pediatric type 1 diabetes management, efforts to support parents in increasing children’s physical activity and reducing screen time are needed, along with readily accessible mental health resources for both parents and their children with type 1 diabetes.

show abstract

Section: Discussionmentioning

confidence: 99%

Impacts of the COVID-19 Pandemic on Pediatric Type 1 Diabetes Management: A Qualitative Study

Ferguson

Moore

Kaidbey

et al. 2022

The Science of Diabetes Self-Management and Care

View full text Add to dashboard Cite

show abstract

“…Full text of 48 articles were read, and among these, 22 studies with 2106 paediatric patients with T1D were included in the final analysis. Eleven studies compared glucose control between the lockdown and pre-lockdown period (3,4,(11)(12)(13)(14)(15)(16)(17)(18)(19); eight studies compared post-lockdown with pre-lockdown period (5,6,(20)(21)(22)(23)(24)(25)(26); three studies compared both lockdown and post-lockdown with pre-lockdown period (26)(27)(28); In most studies the glycaemic data were collected via CGM or FGM. The characteristics of the included studies are presented in Table 1.…”

Section: Literature Searchmentioning

confidence: 99%

The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: A systematic review and meta-analysis of 22 observational studies

et al. 2022

View full text Add to dashboard Cite

IntroductionThe COVID lockdown has posted a great challenge to paediatric patients with type 1 diabetes (T1D) and their caregivers on the disease management. This systematic review and meta-analysis sought to compare the glycaemic control among paediatric patients with T1D (aged under 18 years) pre- during, and post-lockdown period.Methods and materialsWe did a systematic search of three databases (PubMed, Embase, and the WHO COVID‐19 Global literature) for the literature published between 1 Jan 2019 to 10 Sep 2022. Studies meeting the following inclusion criteria were eligible for this study: (1) a COVID-19 related study; (2) inclusion of children aged 18 years old or under with established T1D; (3) comparing the outcomes of interest during or after the COVID lockdown with that before the lockdown. Study endpoints included mean difference (MD) in HbA1c, blood glucose, time in range (TIR, 70-180 mg/dl), time above range (TAR, >180mg/dl), time below range (TBR,<70mg/dl) and glucose variability (coefficient of variation [CV]) between pre-lockdown and during lockdown and/or between pre- and post-lockdown period. The MD and its corresponding 95% CI of each endpoint were pooled using random-effect model considering the potential between-study heterogeneity in COVID restrictions and T1D management.ResultsInitial search identified 4488 records and 22 studies with 2106 paediatric patients with T1D were included in the final analysis. Compared with pre-lockdown period, blood glucose was significantly decreased by 0.11 mmol/L (95%CI: -0.18, -0.04) during lockdown period and by 0.42 mmol/L (95%CI: -0.73, -0.11) after lockdown. The improvement was also found for TIR, TAR, TBR, and CV during and post-lockdown (all p values<0.05) except for the post-lockdown TBR (p =0.35). No significant change in HbA1c was observed during and post- lockdown period when compared with the pre-lockdown value. There was moderate to high between-study heterogeneity for most of the analyses.ConclusionCompared with pre-lockdown period, there was significant improvement in T1D paediatric patients’ glucose metrics during and post-lockdown. The underlying reasons for this positive impact warrant further investigation to inform future paediatric diabetes management.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42022359213.

show abstract

“…3,4,[20][21][22][23][24][25][26][27][28] Other investigators also embraced the power of real-world surveillance and real-world data. 29,30 Big Data, Machine Learning, and Artificial Intelligence…”

Section: Real-world Data and Disease Surveillancementioning

confidence: 99%

Diabetes Population Health Innovations in the Age of COVID-19: Insights From the T1D Exchange Quality Improvement Collaborative

Mungmode¹

2022

JCOM

View full text Add to dashboard Cite

COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020

Cited by 17 publications

References 22 publications

Impacts of the COVID-19 Pandemic on Pediatric Type 1 Diabetes Management: A Qualitative Study

Impacts of the COVID-19 Pandemic on Pediatric Type 1 Diabetes Management: A Qualitative Study

The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: A systematic review and meta-analysis of 22 observational studies

Diabetes Population Health Innovations in the Age of COVID-19: Insights From the T1D Exchange Quality Improvement Collaborative

Contact Info

Product

Resources

About